'Huge Step Forward' in Advanced Ovarian Cancer

Adding both durvalumab and olaparib to standard-of-care treatment in newly diagnosed non-BRCA mutated advanced ovarian cancer represents a 'huge step forward,' says one expert.
Medscape Medical News

source https://www.medscape.com/viewarticle/992740?src=rss

Comments

Popular posts from this blog

DC’s Harllee Harper Is Using Public Health Tools to Prevent Gun Violence. Will It Work?